OpenLobby.EU
Explore

Method for the Collection of data on antimicrobial medicinal products used in animals

Food safety

This initiative will provide the requirements and methods for gathering data on AMR (sale and use of antimicrobials).

Links

Public consultation

ID: 11572

Lobbying Activity

6 responses

Consultation response

Germanwatch, 16 Dec 2020

Guten Abend sehr geehrte Damen und Herren, vielen Dank für die Möglichkeit des Feedbacks. Germanwatch-Feedback, Berlin, 16.12.2020, von Reinhild Benning Germanwatch hat in einem Labor-Test 2020 (https://germanwatch.org/en/19460) bei 165 Hähnchenfleischproben aus 5 EU-Ländern auf 51 % resistente…

Consultation response

AnimalhealthEurope, 18 Dec 2020

AnimalhealthEurope welcomes the opportunity to comment on this draft delegated act. We are supportive of the legal basis given to the ESVAC project in the new regulation. Marketing authorisation holders (MAH) are named as one source of data. This should be changed. With the Union Product Database…

Consultation response

Federation of Veterinarians of Europe, 18 Dec 2020

The Federation of Veterinarians of Europe (FVE), representing about 300 000 veterinarians across Europe, welcomes the possibility to comment on this draft delegated act. We found this draft a balanced proposal and support the legal basis given to the ESVAC project on data collection in respect to…

Consultation response

Access VetMed, 18 Dec 2020

Please find EGGVP comments attached.

Consultation response

Fédération Européenne pour la Santé Animale et la Sécurité Sanitaire, 18 Dec 2020

FESASS thanks the Commission for this public consultation on the draft delegated Regulation on the collection of data on the sale and use of antimicrobials in animals. It is important to continue the exemplary efforts undertaken in the European Union to ensure the effective use of antimicro bial…

Consultation response

Fédération Nationale des Groupements de Défense Sanitaire, 18 Dec 2020

GDS France accueille avec intérêt ce projet de règlement délégué concernant la collecte de données relatives à la vente et à l'utilisation des médicaments antimicrobiens. GDS France partage les préoccupations concernant les risques de développement des antibiorésistances et rappelle parallèlement…